OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
March 17, 2015
Penn Pharma's equipment addition meets growing need for continuous dry granulation and for handling of highly potent drugs.
March 15, 2015
Innovative equipment, analytical techniques, software, and modeling systems are improving the tableting process.
Taste may be subjective, but it is crucial to patient compliance, particularly for pediatric treatments.
Analytical technologies must accurately identify and measure the critical material attributes of APIs and excipients.
PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames.
Ionic liquid technologies offer a new way to improve bioavailability.
New cellulosic polymers have been shown to improve solubility in these key amorphous solid dispersion processes.
March 13, 2015
BIO and the Colorado BioScience Association urge Colorado Governor Hickenlooper to sign a bill that will help patients gain access to interchangeable biologic products following FDA approvals.
March 11, 2015
Drug spending rose last year at the highest rate since 2003, driven by specialty medicines, according to a report from pharmacy benefit manager Express Scripts.
March 06, 2015
Mallinckrodt Pharmaceuticals has bought Ikaria, a privately-held critical care company, for $2.3 billion.